drugset / Trial / NCT07143604
A Study to Investigate the Effects of AZD0901 Monotherapy in Adult Participants With 2L+ Advanced or Metastatic Gastric or GEJ Adenocarcinoma Expressing CLDN18.2
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to measure the efficacy and safety of AZD0901 monotherapy as 2L+ treatment for participants with advanced or metastatic gastric or GEJ adenocarcinoma expressing CLDN18.2.
Timeline
- Start
- 2025-08-29
- Primary completion
- 2026-09-28
- Completion
- 2027-09-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sonesitatug Vedotin | Other / unclassified | — | Intravenous |